Xenetic Biosciences
XBIO
16 hedge funds and large institutions have $535K invested in Xenetic Biosciences in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
7% more funds holding
Funds holding: 15 → 16 (+1)
0.03% less ownership
Funds ownership: 0.72% → 0.69% (-0.03%)
35% less capital invested
Capital invested by funds: $828K → $535K (-$293K)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$15.6K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$11K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$5.49K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$8 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$30K |
| 2 |
Renaissance Technologies
New York
|
-$28.4K |
| 3 |
Morgan Stanley
New York
|
-$5.29K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.13K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$8 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $331K | – | – | – |
|
|
2
Renaissance Technologies
New York
| $62K | -$28.4K | -3,596 | -24% |
|
3
Geode Capital Management
Boston,
Massachusetts
| $49K | – | – | – |
|
4
State Street
Boston,
Massachusetts
| $19K | – | – | – |
|
|
JEST
5
JTC Employer Solutions Trustee
St Helier,
Jersey
| $15K | – | – | – |
|
|
VF
6
Virtu Financial
New York
| $11K | +$15.6K | +1,973 | New |
|
7
Northern Trust
Chicago,
Illinois
| $10K | – | – | – |
|
|
SPIA
8
Steward Partners Investment Advisory
New York
| $10K | – | – | – |
|
|
TSS
9
Two Sigma Securities
New York
| $8K | +$11K | +1,396 | New |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $6K | -$2.13K | -269 | -19% |
|
|
GVAG
11
Great Valley Advisor Group
Wilmington,
Delaware
| $6K | – | – | – |
|
|
12
Morgan Stanley
New York
| $4K | -$5.29K | -670 | -53% |
|
|
13
UBS Group
Zurich,
Switzerland
| $4K | +$5.49K | +694 | +754% |
|
|
14
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$30K | -3,752 | Closed |
|
|
15
Fidelity Investments
Boston,
Massachusetts
| – | -$8 | -1 | -33% |
|
|
16
Wells Fargo
San Francisco,
California
| – | +$8 | +1 | +11% |
|
XBIO Hedge Fund Activity: Q3 2022 in Review
16 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Xenetic Biosciences (XBIO) for Q3 2022, worth a combined $535K — down 35% from $828K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new XBIO positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 4 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $15.6K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $30K sold.
- 16 institutional investors held Xenetic Biosciences (XBIO) as of Q3 2022, up from 15 in Q2 2022.
- Funds reported $535K of Xenetic Biosciences stock for Q3 2022, down 35% quarter-over-quarter.
- 2 funds opened new Xenetic Biosciences positions in Q3 2022 and 1 closed out, a net change of +1 holder.
- The largest Xenetic Biosciences buyer in Q3 2022 was Virtu Financial, an estimated $15.6K added.
- The largest Xenetic Biosciences seller in Q3 2022 was Susquehanna International Group, an estimated $30K sold.
Based on aggregated 13F filings for Q3 2022.